izpis_h1_title_alt

Synthesis of conformationally constrained D-Glu-meso-DAP analogs as innate immune agonists
ID Guzelj, Samo (Author), ID Jakopin, Žiga (Author)

.pdfPDF - Presentation file, Download (1,65 MB)
MD5: CD61878330E2605F69E7C51A7AA198A2
URLURL - Source URL, Visit https://www.mdpi.com/1420-3049/25/22/5228 This link opens in a new window

Abstract
The dipeptide D-Glu-meso-DAP (iE-DAP) is the minimal structural fragment capable of activating the innate immune receptor nucleotide-binding oligomerization domain protein (NOD1). The meso-diaminopimelic acid (meso-DAP) moiety is known to be very stringent in terms of the allowed structural modifications which still retain the NOD1 activity. The aim of our study was to further explore the chemical space around the meso-DAP portion and provide a deeper understanding of the structural features required for NOD1 agonism. In order to achieve the rigidization of the terminal amine functionality of meso-DAP, isoxazoline and pyridine heterocycles were introduced into its side-chain. Further, we incorporated the obtained meso-DAP mimetics into the structure of iE-DAP. Collectively, nine innovative iE-DAP derivatives additionally equipped with lauroyl or didodecyl moieties at the α-amino group of D-Glu have been prepared and examined for their NOD1 activating capacity. Overall, the results obtained indicate that constraining the terminal amino group of meso-DAP abrogates the compounds ability to activate NOD1, since only compound 6b retained noteworthy NOD1 agonistic activity, and underpin the stringent nature of this amino acid with regard to the allowed structural modifications.

Language:English
Keywords:NOD1 agonist, constrained meso-DAP mimetics, NOD1 activation, innate immune agonist, bioisosteric replacement, rigidization
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:FFA - Faculty of Pharmacy
Publication status:Published
Publication version:Version of Record
Year:2020
Number of pages:13 str.
Numbering:Vol. 25, iss. 22, art. 5228
PID:20.500.12556/RUL-134690 This link opens in a new window
UDC:663.2:663.4:547.56:66.094.3.097.8
ISSN on article:1420-3049
DOI:10.3390/molecules25225228 This link opens in a new window
COBISS.SI-ID:36482307 This link opens in a new window
Publication date in RUL:26.01.2022
Views:388
Downloads:161
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Molecules
Shortened title:Molecules
Publisher:MDPI
ISSN:1420-3049
COBISS.SI-ID:18462981 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:10.11.2020

Secondary language

Language:Slovenian
Keywords:agonist prirojene imunosti, bioizosterna zamenjava, NOD1 agonisti, aktivacija NOD1, rigidizirani mimetiki mezo-DAP

Projects

Funder:ARRS - Slovenian Research Agency
Project number:P1-0208
Name:Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin

Funder:ARRS - Slovenian Research Agency
Project number:J3-9256
Name:Razvoj agonistov receptorja NOD2 ter dualnih NOD2/TLR7 agonističnih konjugatov kot novih adjuvansov za cepiva

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back